Cargando…

Enhanced Case Detection and Improved Diagnosis of PKDL in a Kala-azar-Endemic Area of Bangladesh

OBJECTIVES: To support the Bangladesh National Kala-azar Elimination Programme (NKEP), we investigated the feasibility of using trained village volunteers for detecting post-kala-azar dermal leishmaniasis (PKDL) cases, using polymerase chain reaction (PCR) for confirmation of diagnosis and treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mondal, Dinesh, Nasrin, Kamrul Nahar, Huda, M. Mamun, Kabir, Mamun, Hossain, Mohammad Shakhawat, Kroeger, Axel, Thomas, Tania, Haque, Rashidul
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950134/ https://www.ncbi.nlm.nih.gov/pubmed/20957193 http://dx.doi.org/10.1371/journal.pntd.0000832

Ejemplares similares

Low prevalence of Leishmania donovani infection among the blood donors in kala-azar endemic areas of Bangladesh
por: Huda, M Mamun, et al.
Publicado: (2013)

Prevalence of post kala-azar dermal leishmaniasis (PKDL) and treatment seeking behavior of PKDL patients in Nepal
por: Joshi, Anand Ballabh, et al.
Publicado: (2023)

The immunology of post-kala-azar dermal leishmaniasis (PKDL)
por: Zijlstra, Eduard E.
Publicado: (2016)

Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post–kala-azar dermal leishmaniasis (PKDL) patients
por: Owen, Sophie I., et al.
Publicado: (2021)

Accelerated Active Case Detection of Visceral Leishmaniasis Patients in Endemic Villages of Bangladesh
por: Khatun, Jahanara, et al.
Publicado: (2014)

Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL)
por: Adams, Emily R., et al.
Publicado: (2013)

Evaluation of Real-time PCR for Diagnosis of Post-Kala-azar Dermal Leishmaniasis in Endemic Foci of Bangladesh
por: Ghosh, Prakash, et al.
Publicado: (2018)

Malaria Prevalence in Endemic Districts of Bangladesh
por: Haque, Ubydul, et al.
Publicado: (2009)

Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from Bangladesh
por: Mondal, Dinesh, et al.
Publicado: (2019)

Three-Dimensional Optical Scanning in Post–kala-azar Dermal Leishmaniasis (PKDL)
por: Zijlstra, Eduard E., et al.
Publicado: (2020)

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
por: Volpedo, Greta, et al.
Publicado: (2021)

Correction: Malaria Prevalence in Endemic Districts of Bangladesh
por: Haque, Ubydul, et al.
Publicado: (2009)

Risk Factors for Kala-Azar in Bangladesh
por: Bern, Caryn, et al.
Publicado: (2005)

PKDL—A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India
por: Ganguly, Swagata, et al.
Publicado: (2015)

Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study
por: Banjara, Megha R., et al.
Publicado: (2015)

Evidence for Involvement of Th17 Type Responses in Post Kala Azar Dermal Leishmaniasis (PKDL)
por: Katara, Gajendra Kumar, et al.
Publicado: (2012)

Revisiting the diagnosis and treatment of Para Kala-azar Dermal Leishmaniasis in the endemic foci of Bangladesh
por: Maruf, Shomik, et al.
Publicado: (2023)

Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh’s National Kala-azar Elimination Programme
por: Hossain, Md. Sakhawat, et al.
Publicado: (2018)

Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India
por: Ramesh, V., et al.
Publicado: (2015)

Kala-azar in Pregnancy in Mymensingh, Bangladesh: A Social Autopsy
por: Rahman, Kazi Mizanur, et al.
Publicado: (2014)

Correction: Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India
por: Ramesh, V., et al.
Publicado: (2015)

Hypokalaemia-Induced Rhabdomyolysis after Treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL) with High-Dose AmBisome in Bangladesh—A Case Report
por: Marking, Ulrika, et al.
Publicado: (2014)

To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL)
por: Rabi Das, Vidya Nand, et al.
Publicado: (2017)

Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff
por: Maintz, Eva-Maria, et al.
Publicado: (2014)

Report of the Post Kala-Azar Dermal Leishmaniasis (PKDL) consortium meeting, New Delhi, India, 27–29 June 2012
por: Desjeux, Philippe, et al.
Publicado: (2013)

Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study
por: Verma, Neena, et al.
Publicado: (2015)

Indoor residual spraying for kala-azar vector control in Bangladesh: A continuing challenge
por: Chowdhury, Rajib, et al.
Publicado: (2018)

Short Communication: Evaluation of a New Rapid Diagnostic Test for Quality Assurance by Kala Azar Elimination Programme in Bangladesh
por: Khan, Md Gulam Musawwir, et al.
Publicado: (2011)

How do health care providers deal with kala-azar in the Indian subcontinent?
por: Kumar, Narendra, et al.
Publicado: (2011)

Implication of vector characteristics of Phlebotomus argentipes in the kala-azar elimination programme in the Indian sub-continent
por: Chowdhury, Rajib, et al.
Publicado: (2016)

Foxp3 and IL-10 Expression Correlates with Parasite Burden in Lesional Tissues of Post Kala Azar Dermal Leishmaniasis (PKDL) Patients
por: Katara, Gajendra Kumar, et al.
Publicado: (2011)

Post-Kala-Azar Dermal Leishmaniasis in Mymensingh, Bangladesh
por: Islam, Shamim, et al.
Publicado: (2011)

Kala-Azar
por: Murugesan, P.
Publicado: (1915)

Kala Azar
Publicado: (1896)

Kala Azar
Publicado: (1896)

Kala Azar
por: Grant, A. E.
Publicado: (1897)

Kala Azar
por: O'Gorman, P. W.
Publicado: (1896)

Kala-Azar
por: Colaco, B.
Publicado: (1886)

Kala-Azar
Publicado: (1918)

Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case–control study protocol
por: Mondal, D, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sr287arpp39rnh84ct7kb727k9